A detailed history of Amalgamated Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 65,674 shares of MRNA stock, worth $2.42 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
65,674
Previous 66,775 1.65%
Holding current value
$2.42 Million
Previous $7.93 Million 44.65%
% of portfolio
0.04%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$63.64 - $125.14 $70,067 - $137,779
-1,101 Reduced 1.65%
65,674 $4.39 Million
Q2 2024

Aug 12, 2024

SELL
$101.21 - $166.61 $213,553 - $351,547
-2,110 Reduced 3.06%
66,775 $7.93 Million
Q1 2024

Apr 23, 2024

SELL
$85.37 - $115.44 $907,056 - $1.23 Million
-10,625 Reduced 13.36%
68,885 $7.34 Million
Q4 2023

Feb 06, 2024

SELL
$69.51 - $104.43 $383,625 - $576,349
-5,519 Reduced 6.49%
79,510 $7.91 Million
Q3 2023

Nov 08, 2023

BUY
$96.41 - $126.61 $70,282 - $92,298
729 Added 0.86%
85,029 $8.78 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $180,001 - $243,845
-1,519 Reduced 1.77%
84,300 $10.2 Million
Q1 2023

May 02, 2023

SELL
$135.66 - $197.02 $140,408 - $203,915
-1,035 Reduced 1.19%
85,819 $13.2 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $14,442 - $25,624
-122 Reduced 0.14%
86,854 $15.6 Million
Q3 2022

Nov 09, 2022

SELL
$118.07 - $194.18 $133,655 - $219,811
-1,132 Reduced 1.28%
86,976 $10.3 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $453,995 - $684,462
-3,876 Reduced 4.21%
88,108 $12.6 Million
Q1 2022

Jun 30, 2022

BUY
$126.46 - $235.05 $499,517 - $928,447
3,950 Added 4.49%
91,984 $15.8 Million
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $1.97 Million - $3.22 Million
8,744 Added 11.03%
88,034 $22.4 Million
Q3 2021

Oct 29, 2021

BUY
$221.9 - $484.47 $12.1 Million - $26.5 Million
54,655 Added 221.86%
79,290 $30.5 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $1.38 Million - $2.49 Million
10,585 Added 75.34%
24,635 $5.79 Million
Q1 2021

May 13, 2021

SELL
$109.18 - $185.98 $91,274 - $155,479
-836 Reduced 5.62%
14,050 $1.84 Million
Q4 2020

Feb 12, 2021

SELL
$65.74 - $169.86 $14,331 - $37,029
-218 Reduced 1.44%
14,886 $1.56 Million
Q3 2020

Oct 30, 2020

BUY
$54.34 - $94.85 $34,723 - $60,609
639 Added 4.42%
15,104 $1.07 Million
Q2 2020

Aug 10, 2020

SELL
$29.67 - $80.0 $1.23 Million - $3.32 Million
-41,451 Reduced 74.13%
14,465 $929,000
Q1 2020

May 13, 2020

BUY
$17.78 - $31.58 $47,454 - $84,287
2,669 Added 5.01%
55,916 $1.68 Million
Q4 2019

Feb 13, 2020

BUY
$13.93 - $21.28 $51,387 - $78,501
3,689 Added 7.44%
53,247 $1.04 Million
Q3 2019

Nov 13, 2019

BUY
$12.26 - $18.07 $607,581 - $895,513
49,558 New
49,558 $789,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.